Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Young, Carolyn A ORCID: 0000-0001-6971-8203, Rog, David J, Sharrack, Basil, Tanasescu, Radu, Kalra, Seema, Harrower, Timothy, Tennant, Alan, Mills, Roger J ORCID: 0000-0001-6341-6220 and Trajectories of Outcome in Neurological Conditions-MS Study Grou,
(2023) Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. pp. 1-9.


Brittain, Gavin, Petrie, Jennifer, Duffy, Kate EM, Glover, Rachel, Hullock, Katie, Papaioannou, Diana, Roldan, Elisa, Beecher, Colette, Bursnall, Matthew, Ciccarelli, Olga
et al (show 19 more authors) (2024) Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open, 14 (2). e083582-e083582.


Chataway, Jeremy, De Angelis, Floriana, Connick, Peter, Parker, Richard A, Plantone, Domenico, Doshi, Anisha, John, Nevin, Stutters, Jonathan, MacManus, David, Carrasco, Ferran Prados
et al (show 44 more authors) (2020) Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. LANCET NEUROLOGY, 19 (3). pp. 214-225.


Young, Carolyn J, Rog, David, Sharrack, Basil, Constantinescu, Cris, Kalra, Seema, Harrower, Tim, Langdon, Dawn, Tennant, Alan J and Mills, Roger
(2023) Measuring disability in multiple sclerosis: the WHODAS 2.0. QUALITY OF LIFE RESEARCH, 32 (11). pp. 3235-3246.


Connick, Peter, De Angelis, Floriana, Parker, Richard A, Plantone, Domenico, Doshi, Anisha, John, Nevin, Stutters, Jonathan, MacManus, David, Prados Carrasco, Ferran, Barkhof, Frederik
et al (show 15 more authors) (2018) Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ open, 8 (8). e021944-e021944.

This list was generated on Mon Apr 8 13:07:27 2024 BST.